Antimony potassium tartrate

DB15587ExperimentalSmall molecule

Antimony potassium tartrate is a schistosomicide possibly useful against other parasites. It has irritant emetic properties and may cause lethal cardiac toxicity among other adverse effects.

Formula / weight: C₈H₁₀K₂O₁₅Sb₂ · 667.87 g/mol (avg)
Also known as: Potassium antimonyl D-tartrate · Potassium antimonyl tartrate · Tartar emetic · Tartarized antimony · Tartox

Resolves to

Compound

UNIIDL6OZ476V3CAS28300-74-5KEGGD02959

Clinical / RWD

RxNorm981

Structure

InChIKeyWBTCZEPSIIFINA-MSFWTACDSA-JSMILESO.O.O.[K+].[K+].[Sb+3].[Sb+3].[O-][C@H]([C@@H]([O-])C([O-])=O)C([O-])=O.[O-][C@H]([C@@H]([O-])C([O-])=O)C([O-])=O

Targets

P08237PFKM

Transporters

P33527ABCC1

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1TransporterSubstrate / inhibitor direction, not just membership

Listed above

3Structured indicationsCondition, population, route and combination as fields, not prose

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Antimony potassium tartrate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account